Conference Coverage
Conference Coverage
What drives treatment satisfaction among adults with atopic dermatitis?
Adults with AD and lower income, no health insurance, and multimorbidity had even lower treatment satisfaction.
Conference Coverage
Sleep apnea and cognitive impairment are common bedfellows
“People with cognitive impairment should be assessed for sleep apnea if they have difficulty with sleep or if they demonstrate sleep-related...
Conference Coverage
Novel oral agent effective in teens with atopic dermatitis
Teens who received abrocitinib along with medicated topical therapy showed significant improvement in the severity of their AD at the end of the...
Conference Coverage
RA experts highlight key developments over the past year
Highlights include lymphoma risk reduction with biologics, low-dose corticosteroid risk, stratifying VTE risk, treat-to-target strategies and...
Conference Coverage
Severe atopic dermatitis often puts a dent in quality of life
“There have been many surveys of adults with AD who report impairment of their sleep, reduced activity level, increased work absence, financial...
Conference Coverage
Novel agent shows promise against cat allergy
“We clearly demonstrate that these antibodies decrease the asthmatic response to cat allergen within 8 days, and that these effects last 3 months...
Conference Coverage
Mepolizumab reduced exacerbations in patients with asthma and atopy, depression comorbidities
Few studies have examined the efficacy of mepolizumab therapy for patients with asthma and comorbidities.
Conference Coverage
Patients with asthma say most doctors don’t ask about cannabis use
Smoking cannabis could lead to increased symptoms of cough and wheeze.
Conference Coverage
Peanut sublingual immunotherapy feasible and effective in toddlers
There was a “strong potential” for sustained unresponsiveness at 3 months for the toddlers who received the active treatment.
Conference Coverage
Asthma not an independent risk factor for severe COVID-19, hospitalization
There have been conflicting data on whether comorbid asthma is or is not a risk factor for more severe COVID-19.
Conference Coverage
Frequent medication refills show some patients not achieving asthma control
Prescription of systemic corticosteroids and short-acting beta agonists can indicate poor asthma control.